FIT grants CHF 400'000 to four new Western Switzerland startups

06.08.2018 13:41
Swiss Francs

Largo Films, Aeler Technologies, Gliapharm and Ligentec are the four latest winners of the Foundation for Technological Innovation (FIT) seed loan. Each startup received CHF 100’000 to further develop their business.

The Foundation for Technological Innovation provides financial supports to innovative and technological projects at different development stages. The FIT seed loan is targeted at companies that are not older than one year helping them in the prototyping and commercial development phase of a product. The four newly supported start-ups are:

Largo Films (EPFL): A novel streaming platform for short films with the innovative features increasing the engagement of audience

Largo develops Sofy.tv, an innovative video on-demand platform dedicated to movies shorter than 40 minutes. Largo’s technology allows targeted movies recommendations to the right audience, bringing engagement to new heights. Sofy.tv comes at the right time: recently number of short films have increased a lot and they have become a new trend for a wider audience. The platform was launched in May. Largo will now use the support from the FIT for the technology transfer.

Aeler Technologies (EPFL): A novel container for freight transportation

The EPFL startup is rethinking a fundamental tool of international freight transportation: the shipping container. Aeler builds a 21st century-ready composite intermodal container embedded with state-of-the-art electronics and sensors. Through this tool, Aeler shall reduce operating costs during transport, increase security and safety, reduce fuel consumption and related emissions, and enable IoT traceability and visibility services at the level of the container. The CHF 100’000 FIT loan will be used to create a real size prototype and use it with industrial partners for a first pilot phase. 

Gliapharm (EPFL): A new approach to the treatment of neurological and psychiatric disorder

The biotechnology startup GliaPharm develops treatments that are targeted at neurological and psychiatric disorders. Their innovative therapeutic approach is to target Glial Cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. The support from the FIT shall help GliaPharm to bring its mission to reality, which is to become a leading biotechnology company.  

LIGENTEC: Optical networks based on integrated silicon nitride photonics

LIGENTEC performs the research, development, fabrication and commercialisation of components and products related to optical systems based on integrated silicon nitride photonics. LIGENTEC reduces big optical systems to sizes smaller than a fingerprint. These optical systems also become more efficient in energy, thanks to new functionalities. LIGENTEC is present in markets such as telecommunications, quantum computing and bio-detection. Venture Kick and ESA-BIC support the start-up, too

(SK)

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines

Please login or
register to use the
bookmark feature

Principal

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS

In order to provide the best quality for you, our system uses "cookies", which are stored on your device. Cookies are necessary to identify what information (job advertisement, questionnaire, etc) you have already seen. IP address is used for the same purposes as described above.

When creating a profile, applying to the newsletter, job subscriptions and etc, you agree that the data, which you have entered, will be stored and processed in the system in order to provide services, which you have applied for.

We do NOT sell your personal data to any 3rd party services.

You must be 18 or older years old to use our services. If you are underage, you must have a permission to use our services from your parent or guardian. It is necessary in order to store and process your data.

By continuing to use our services, you agree with the these terms. You can withdraw your agreement at any time, by deleting cookies from your device and by sending request for deleting your data to the administrator.